Literature DB >> 13811574

Massive nitrogen mustard therapy in Hodgkin's disease with protection of bone marrow by tourniquets.

M E CONRAD, W H CROSBY.   

Abstract

Entities:  

Keywords:  BONE MARROW; HODGKIN'S DISEASE/therapy; NITROGEN MUSTARDS/therapy

Mesh：

Substances：

Year:  1960        PMID： 13811574

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  7 in total

1.  [REGIONAL CHEMOTHERAPY OF MALIGNANT TUMORS. II. TREATMENT WITH MASSIVE DOSES OF NITROGEN MUSTARD WITH TEMPORARY COMPRESSION OF THE ABDOMINAL AORTA AND ITS COLLATERAL ARTERIES].

Authors:  H F OETTGEN; P CLIFFORD; J L BEECHER; J H GILLMORE
Journal:  Klin Wochenschr       Date:  1964-03-01

2.  Drug-induced blood dyscrasias.

Authors:  P G WEIL
Journal:  Can Med Assoc J       Date:  1962-09-29       Impact factor: 8.262

3.  Regional protection in cancer chemotherapy. 1. Infusions of thymidine into external carotid artery of patients receiving systemic 5-iodo-2'-deoxyuruidine.

Authors:  P CALABRESI
Journal:  J Clin Invest       Date:  1962-07       Impact factor: 14.808

4.  Chemotherapy of intrathoracic neoplasms employing differential pelvic perfusion hypothermia.

Authors:  W G YOUNG; A M LESAGE; M L DILLON; J M LEE; H A CALLAWAY; J W REEVES
Journal:  Ann Surg       Date:  1961-09       Impact factor: 12.969

5.  Enzyme alterable alkylating agents. 8. Clinical trials with intra-arterial infusion of an alkylating agent with a half-life of 0.2 second.

Authors:  L E Goodman; A Ulfohn; S P Kramer; E H Cendana; A B Flores; D Bakal; S J Abrams; R L Hirschfeld; S Calle; C E Williamson; S Sass; B Witten; A M Seligman
Journal:  Ann Surg       Date:  1965-10       Impact factor: 12.969

6.  The Clinical Application of Bone Marrow Grafting.

Authors:  D E Pegg; J G Humble; K A Newton
Journal:  Br J Cancer       Date:  1962-09       Impact factor: 7.640

Review 7.  Stepping forward in antibody-drug conjugate development.

Authors:  Yiming Jin; Megan A Schladetsch; Xueting Huang; Marcy J Balunas; Andrew J Wiemer
Journal:  Pharmacol Ther       Date:  2021-06-24       Impact factor: 12.310
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.